Biotechnology Cardiology Clinical Trials Coronavirus Coronavirus COVID-19 drug development Infectious Diseases rare diseases Potential new drug to mitigate SARS-CoV-2 infection consequences By Staff Reports 1 week ago Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the
Biotechnology cancer Clinical Trials drug development New Treatment Developed by Children’s Hospital of Philadelphia Shows Success in High-Risk Solid Tumors By Staff Reports 1 month ago Despite intensive treatment, high-risk solid tumors like neuroblastoma, Ewing sarcoma, and rhabdomyosarcoma are challenging to
Biotechnology Coronavirus Coronavirus COVID-19 drug development UCI scientists get ‘initial hit’ in developing drug to treat COVID-19 By Staff Reports 2 months ago When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and
Biotechnology cancer Clinical Trials drug development New chemotherapy drug studied for malignant brain tumor in children By Staff Reports 4 months ago MTX110 is a new formulation of panobinostat, a chemotherapy drug that has shown promise in
Biotechnology Clinical Trials Coronavirus drug development rare diseases Clinical trial in COVID-19 patients tests anti-inflammatory drug developed 25 years ago at Scripps Research By Staff Reports 5 months ago An anti-inflammatory drug developed at Scripps Research 25 years ago is now being tested as
Biotechnology Clinical Trials Coronavirus drug development Pharmaceuticals rare diseases FDA-approved drugs could help fight COVID-19 By Staff Reports 6 months ago Drugs that are already approved by the U.S. Food and Drug Administration (FDA) could hold
Biotechnology Clinical Trials drug development Combination of engineered cold sore virus and inhibitor drugs could destroy brain tumors By Staff Reports 7 months ago Researchers who discovered that an engineered cold sore virus could help destroy brain tumors from
Biotechnology Clinical Trials drug development Health and Wellness Injuries Researchers find drug combination that can accelerate bone healing By Staff Reports 7 months ago U.K. and U.S. scientists have discovered a combination of two commonly available drugs could boost
Biotech Company News Biotechnology cancer Cell Therapy Clinical Trials drug development Researchers Identify New Therapeutic Target for Colorectal Cancer By Staff Reports 9 months ago Researchers at the University of Toronto have identified a key protein that supports the growth
Biotechnology Clinical Trials drug development Strokes Investigational Drug for People with Treatment-Resistant Epilepsy By Staff Reports 10 months ago Imagine not being able to drive, shower alone or even work because you are never
Biotechnology cancer Clinical Trials drug development Rehabilitation and Medicine One-two punch drug combination offers hope for pancreatic cancer therapy By Staff Reports 11 months ago Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a combination of two anti-cancer
Biotechnology cancer Clinical Trials drug development Immunotherapies Investigational Drug with Immunotherapy May Provide New Therapeutic Opportunity for Patients Previously Treated for Kidney and Lung Cancer By Staff Reports 1 year ago Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may
Biotechnology cancer Clinical Trials drug development Gene Therapy MicroRNA-based Therapy May be New Weapon to Combat Cancer By Staff Reports 1 year ago A technology that manipulates microRNAs (miRNAs) developed by Jingfang Ju, PhD, a biochemist and Professor
Biotechnology cancer Clinical Trials drug development New drug shows encouraging survival in pancreatic cancer By Staff Reports 1 year ago A clinical trial testing a new drug in pancreatic cancer had promising initial results, report
Biotechnology drug development genes Pharmaceuticals rare diseases Single Enzyme Helps Drive Inflammation in Mice, Provides Target for New Sepsis Drugs By Staff Reports 1 year ago Sepsis occurs when the body goes overboard in its attempt to fight off an infection.
Biotechnology cancer drug development Hepatitis Study Proves Hepatitis C Drugs Reduce Liver-Related Deaths by Nearly Half By Staff Reports 1 year ago A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for
Biotechnology cancer Cell Therapy Clinical Trials drug development Pancreatic Cancer: Less Toxic, More Enduring Drug May Improve Therapy By Staff Reports 1 year ago Unlike many other cancers, most pancreatic tumors are rock hard. “That’s one reason why pancreatic
cancer Clinical Trials drug development Immunotherapies Zhang group identifies gene that may make triple-negative breast cancer cells vulnerable to existing drug By Staff Reports 1 year ago Certain therapies that have proven effective in treating some types of breast cancers are ineffective
Biotechnology cancer drug development Immunotherapies Scientists develop promising drug for treating ovarian and pancreatic cancers By Staff Reports 1 year ago Known as two of the most lethal cancers, ovarian and pancreatic cancer are often called
Biotechnology drug development Uncategorized Study Shows Experimental Drug Can Encourage Bone Growth in Children with Dwarfism By Staff Reports 1 year ago Researchers at Johns Hopkins Medicine, the Murdoch Children’s Research Institute in Australia and seven other